Recent Trends in Antifungal Agents: A Reference to Formulation, Characterization and Applications

Q2 Pharmacology, Toxicology and Pharmaceutics
K. Pawar, R. Gadhave, Swati Waydande, P. Pawar
{"title":"Recent Trends in Antifungal Agents: A Reference to Formulation, Characterization and Applications","authors":"K. Pawar, R. Gadhave, Swati Waydande, P. Pawar","doi":"10.2174/2210303109666190508082009","DOIUrl":null,"url":null,"abstract":"\n\n Fungi are the heterotrophic eukaryotic organisms which are\nuseful as they causes the biodegradation. There are still some harmful species like yeasts, molds and dermatophytes\nwhich cause the infections. As the fungi are eukaryotics, they do not respond to the antibiotic\ntherapy due to the limitations associated with the traditional antibiotic therapies. There are several antifungal\nagents introduced to treat such infections. These antifungal agents posses severe problems like drug\nresistance and toxicity due to the higher dose which comprises the need for newer alternatives over\nconventional dosage forms. Novel drug delivery systems proved to be a better approach to enhance the\neffectiveness of the antifungals and enhance patient compliance by reducing the adverse effect.\n\n\n\nThis review focused on the general information about fungal infections, types and mechanism\nof action of antifungal agents and overview of formulation approaches such as vesicular system, colloidal\nsystem, nanoparticulate system and in situ gelling which are often studied for antifungal treatments.\n\n\n\nWe concluded that the novel drug delivery systems are the essential techniques for delivering\nthe antifungal agents to their target site with desired concentration. Moreover, the researchers focused\non these novel drug deliveries which mainly concentrate on controlling & sustaining the release\nof antifungal agents.\n","PeriodicalId":11310,"journal":{"name":"Drug Delivery Letters","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Delivery Letters","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2210303109666190508082009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 1

Abstract

Fungi are the heterotrophic eukaryotic organisms which are useful as they causes the biodegradation. There are still some harmful species like yeasts, molds and dermatophytes which cause the infections. As the fungi are eukaryotics, they do not respond to the antibiotic therapy due to the limitations associated with the traditional antibiotic therapies. There are several antifungal agents introduced to treat such infections. These antifungal agents posses severe problems like drug resistance and toxicity due to the higher dose which comprises the need for newer alternatives over conventional dosage forms. Novel drug delivery systems proved to be a better approach to enhance the effectiveness of the antifungals and enhance patient compliance by reducing the adverse effect. This review focused on the general information about fungal infections, types and mechanism of action of antifungal agents and overview of formulation approaches such as vesicular system, colloidal system, nanoparticulate system and in situ gelling which are often studied for antifungal treatments. We concluded that the novel drug delivery systems are the essential techniques for delivering the antifungal agents to their target site with desired concentration. Moreover, the researchers focused on these novel drug deliveries which mainly concentrate on controlling & sustaining the release of antifungal agents.
抗真菌药物的最新发展趋势:配方、表征和应用参考
真菌是一种异养的真核生物,可引起生物降解。仍然有一些有害的物种,如酵母、霉菌和皮肤癣菌,会引起感染。由于真菌是真核生物,由于传统抗生素治疗的局限性,它们对抗生素治疗没有反应。有几种抗真菌药物被用来治疗这种感染。这些抗真菌剂具有严重的问题,如耐药性和毒性,这是由于更高的剂量,包括需要新的替代品,过度传统的剂型。新型给药系统被证明是一种更好的方法,可以通过减少不良反应来提高抗真菌药物的有效性并提高患者的依从性。本文综述了真菌感染的一般信息、抗真菌药物的类型和作用机制,以及常用于抗真菌治疗的泡囊系统、胶体系统、纳米颗粒系统和原位胶凝等制剂方法的综述。我们得出的结论是,新型药物递送系统是以所需浓度将抗真菌药物递送到靶位点的基本技术。此外,研究人员专注于这些新的药物递送,主要集中在控制和维持抗真菌药物的释放。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug Delivery Letters
Drug Delivery Letters Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
CiteScore
1.70
自引率
0.00%
发文量
30
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信